19.42

2.51% -0.50

After Hours: 19.97 0.55 +2.83%

Beta Bionics Inc (BBNX)

Overview News Price History Discussions Forecast

Beta Bionics Inc stock is traded at $19.42, with a volume of 1.41M. It is down -2.51% in the last 24 hours and up +33.29% over the past month. Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Previous Close:

$19.92

Open:

$19.55

24h Volume:

1.41M

Relative Volume:

1.24

Market Cap:

$873.70M

Revenue:

$110.24M

Net Income/Loss:

$-66.44M

P/E Ratio:

-12.85

EPS:

-1.5111

Net Cash Flow:

$-61.12M

1W Performance:

-1.52%

1M Performance:

+33.29%

6M Performance:

+70.65%

1Y Performance:

-3.38%

1-Day Range:

$19.00

$19.97

1-Week Range:

$18.91

$20.23

52-Week Range:

$8.80

$32.71

Beta Bionics Inc Stock (BBNX) Company Profile

Name

Beta Bionics Inc

Sector

Healthcare (1074)

Industry

Medical Devices (141)

Phone

949-427-7785

Address

11 HUGHES, IRVINE

Employee

423

Twitter

Next Earnings Date

2026-07-29

Latest SEC Filings

BBNX's Discussions on Twitter

Compare BBNX vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BBNX Beta Bionics Inc	19.42	876.40M	110.24M	-66.44M	-61.12M	-1.5111
ABT Abbott Laboratories	108.33	197.51B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	94.17	118.14B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	303.13	125.70B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	47.80	71.55B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.90	51.78B	6.30B	1.07B	1.09B	1.8406

Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-26	Initiated	UBS	Buy
Jan-27-26	Initiated	TD Cowen	Hold
Jan-09-26	Downgrade	BofA Securities	Buy → Neutral
Oct-21-25	Resumed	Stifel	Buy
Oct-01-25	Upgrade	Goldman	Neutral → Buy
Jun-16-25	Initiated	Truist	Buy
Jun-12-25	Initiated	Lake Street	Buy
May-30-25	Initiated	Goldman	Neutral
May-30-25	Initiated	Wolfe Research	Outperform
Feb-24-25	Initiated	BofA Securities	Buy
Feb-24-25	Initiated	Lake Street	Buy
Feb-24-25	Initiated	Leerink Partners	Outperform
Feb-24-25	Initiated	Piper Sandler	Overweight
Feb-24-25	Initiated	Stifel	Buy
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral
Feb-20-25	Initiated	Robert W. Baird	Neutral

View All

Beta Bionics Inc Stock (BBNX) Latest News

Aug 21, 2026

Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics - TradingView

Aug 21, 2026

Beta Bionics (NASDAQ:BBNX) Now Covered by William Blair - MarketBeat

Aug 21, 2026

William Blair initiates Beta Bionics stock rating at Market Perform - Investing.com

Aug 21, 2026

Aug 20, 2026

Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders - GlobeNewswire

Aug 20, 2026

Aug 18, 2026

Beta Bionics (NASDAQ:BBNX) Trading 4.7% HigherHere's Why - MarketBeat

Aug 18, 2026

Aug 14, 2026

Beta Bionics (BBNX) Q2 2026 Earnings Call Transcript - AOL.com

Aug 14, 2026

Aug 13, 2026

Farallon group discloses 595,000-share Beta Bionics (BBNX) stake in 13G/A - Stock Titan

Aug 13, 2026

Aug 12, 2026

BofA Securities Maintains Beta Bionics(BBNX.US) With Hold Rating, Raises Target Price to $18 - Moomoo

Aug 12, 2026

BofA Securities Adjusts Price Target on Beta Bionics to $18 From $15.50 - marketscreener.com

Aug 12, 2026

Aug 11, 2026

Beta Bionics, Inc. Stock 12‑Month Price Target Raised to $20.31, Implies 24% Upside - TradingView

Aug 11, 2026

BofA Securities Adjusts Beta Bionics Price Target to $18 From $15.50 - marketscreener.com

Aug 11, 2026

Aug 07, 2026

Beta Bionics (NASDAQ:BBNX) Shares Up 13.7%Should You Buy? - MarketBeat

Aug 07, 2026